LivaNova plc (LIVN) Announces FDA Approval of VNS Therapy Treatment for Drug-Resistant Epilepsy in Children
Tweet Send to a Friend
LivaNova PLC (NASDAQ: LIVN) today announced it received FDA approval of its VNS Therapy® system (“VNS Therapy”) in patients as ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
